Experts in Residence
The “Experts in Residence” scheme is managed by the Translational Research Office. It aims to give Oxford's research community access to world-leading expertise and advice across multiple industry sectors. Scientists can arrange meetings with our experts to discuss their ideas and projects with no strings attached. We expect that this advice and support will help scientists develop the translational strategy for their projects/technologies.
Our Experts
Book a meeting with one of our Experts in Residence
Product Design in Biomedical Engineering
Dr Patrick Hall, Managing Director, Designing Science Ltd
Dr Kerry Briggs, VP Design and Development Europe, Kinneir Dufort
Dr James Holmes, Head of Electronics, Kinneir Dufort
Dr Rouzet Agaiby, Director, EG technology
Dr Giles Sanders, Head of In Vitro Diagnostics, TTP
Dr Stuart Lowe, Head - Biotechnology, Cell and Gene Therapy, TTP
Imaging technologies
Dr Jan Wolber, Product Leader - Digital, GE Healthcare Pharmaceutical Diagnostics
Drug Discovery and development
Dr Rachel Grimley, Senior Vice President, Drug discovery, Cancer Research UK
Professor Simon Hollingsworth, VP, Global Medicine Leader, AstraZeneca
Dr Rachel Hemsley, Business Development Director, Sygnature Discovery
Dr Colin T Dourish, Director and Co-Owner of Blue Day Healthcare
Dr Anthony Brown, VP Business Development & Scientific Liaison, Carrick Therapeutics
Dr Holger Hess-Stumpp, Head of Strategic Alliances and Business Development in DKFZ Innovation Management
Professor David Reynolds, CEO of LoQus 23 and AstronauTx
Dr Tom Oakley, Founder and Principal Consultant - Somerville Development Partners
Dr Andrew Teasdale, Senior Principal Scientist Impurity Management and External
Dr Yatish Lad, Vice President, Head of Early Development, Oxford Biomedica (UK) Ltd.
Dr Andy Pearce, Global Project Leader, AstraZeneca
Digital Health
Dr Steve Gardner, Co-founder and CEO, PrecisionLife
Dr Veronique Bouchet, Chief Medical Officer, PrecisionLife;
Dr Paul O'Donohoe, Senior Director, eCOA Product and Science at Medidata Solutions
Dr Bobby Kaura, Seed Investment, EMEA Outreach & International Development, Illumina Accelerator
Medical Technologies - Regulatory and Market Access
Dr Toni Day, Director of Quality and Regulatory Affairs at OrganOx
Dr Richard Hall, Director, QMS Consultancy
Dr Ben Wensley-Stock, Chief Executive Officer MPS-UK and Wensley Stock Ltd
Dr Steven Haken, Managing Director at Odelle Technology
Amy Peters, Senior Director, Government Affairs and Policy, Johnson and Johnson MedTech
Diagnostics
Clinical Research
Dr Steve McConchie, Operations & Partnership Director for Lean Life Science
Dr Matthew Reaney, Head of Global Science & Analytics, Patient Centered Solutions, IQVIA
Professor Jeremy Kirk, R&D Director Birmingham Women and Children’s Hospital and former CD NIHR Clinical Research Network for West Midlands
Innovation and commercial opportunities
Paul Cox, General Manager UK, Ireland and Nordics, Apellis Pharmaceuticals
Dr Nicholas Duggan, Founder at Zuas
Dr Joanne Hackett, Vice President Genomic and Precision, IQVIA
Dr Laura Ferguson, Associate Director at AstraZeneca
Dr Karen Wai, Chief Executive Officer, DentX